Showing results 1 to 8 of 8
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
2021 | ||||
Cost-effectiveness of Pembrolizumab as a Second-Line Therapy for Hepatocellular Carcinoma Journal:JAMA Network Open | 2021 | 31 | ||
2012 | 189 | |||
Optimizing resource allocation for breast cancer prevention and care among Hong Kong Chinese women: a generalized cost-effectiveness analysis Proceeding/Conference:Health Research Symposium | 2014 | 29 | ||
Resource allocation for breast cancer prevention and care in Hong Kong: a generalized cost-effectiveness analysis Proceeding/Conference:HKCCM 2011 Annual Scientific Meeting | 2011 | 59 | ||
Risk of second primary malignancy in differentiated thyroid carcinoma treated with radioactive iodine therapy Journal:Surgery (United States) | 2012 | 170 | ||
2021 | ||||
Using Risk Stratification to Optimize Mammography Screening in Chinese Women Journal:JNCI Cancer Spectrum | 2021 | 40 |